ApexiCon E is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat inflammation and itching associated with skin conditions that respond to corticosteroids. ApexiCon E is also known by its drug name, diflorasone diacetate.
ApexiCon E is a high-potency corticosteroid. ApexiCon E is believed to work by suppressing immune system activity.
How do I take it?
Prescribing information states that ApexiCon E is applied topically to the affected area one to three times daily.
ApexiCon E comes in the form of a cream.
The FDA-approved label for ApexiCon E lists common side effects including burning, itching, redness, irritation, dryness, papular (raised) rashes, skin atrophy (thinning, wrinkling, or visible depressions in the skin), allergic contact dermatitis, secondary infection, stretch marks, hyperpigmentation (darkening skin color), and thickening of the skin.
Rare but serious side effects listed for corticosteroids include glaucoma, high blood sugar, and reversible hypothalamic-pituitary-adrenal axis suppression (a dysfunction of the adrenal system).
For more details about this treatment, visit:
ApexiCon E — ANI Pharmaceuticals
Prescription Topicals — National Eczema Association